PMID: 6410638Apr 1, 1983Paper

The expanding clinical use of C-peptide radioimmunoassay

Acta diabetologica latina
M Rendell

Abstract

C-peptide levels are in many ways a better measure of endogenous insulin secretion than peripheral insulin levels. C-peptide may be measured in either blood or urine. Perhaps the major advantage of measuring C-peptide levels is the ability to readily distinguish endogenous insulin levels in the presence of exogenous administration of insulin. Early C-peptide immunoassays were troubled by lack of sensitivity. This problem has now been overcome, and it is possible to measure C-peptide values down to extremely low levels. The clinical indications for C-peptide measurement include diagnosis of insulinoma and differentiation from factitious hypoglycemia, follow-up of pancreatectomy and evaluation of viability of islet cell transplants. Recently these indications have been dramatically expanded to permit evaluation of insulin dependence in maturity onset diabetes mellitus.

References

Jul 22, 1976·The New England Journal of Medicine·D L HorwitzA H Rubenstein
Jan 1, 1977·Acta Paediatrica Scandinavica. Supplement·L G Heding, J Ludvigsson
Jan 1, 1978·Diabetes·W BeischerE F Pfeiffer
Jun 1, 1979·The Journal of Clinical Endocrinology and Metabolism·P J SavageP H Bennett
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·H KuzuyaO K Faber
Jan 1, 1978·Diabetes·O K FaberA H Rubenstein
Jan 1, 1978·Diabetes·T KuzuyaH Kajinuma
Jan 1, 1978·Diabetes·C KühlS L Jensen
Jan 1, 1978·Diabetes·D G JohnstonC Binder
Jan 1, 1978·Diabetes·O K FaberC Binder
Jan 1, 1978·Diabetes·D L HorwitzP M Blix
Jul 1, 1978·The Journal of Clinical Investigation·O K FaberN Rossing
Jun 1, 1976·Hoppe-Seyler's Zeitschrift für physiologische Chemie·O K FaberC Binder
Jun 1, 1975·The Journal of Clinical Investigation·D L HorwitzA H Rubenstein
Aug 2, 1975·British Medical Journal·D R HaddenK D Buchanan
Jun 1, 1975·Diabetologia·L G Heding, S M Rasmussen
Nov 1, 1975·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·H OyamaN Suetsugu
Sep 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·F MelaniD F Steiner
May 6, 1971·The New England Journal of Medicine·R A GutmanL Recant
Nov 1, 1974·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G FinkL Recant
May 1, 1973·The Journal of Clinical Investigation·A I Katz, A H Rubenstein
Dec 1, 1973·Annals of Internal Medicine·S M Genuth
Mar 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·R W StollR H Williams
Jul 14, 1969·JAMA : the Journal of the American Medical Association·A H Rubenstein
Dec 1, 1967·The Journal of Clinical Investigation·M J Perley, D M Kipnis
Dec 1, 1983·The Journal of Clinical Endocrinology and Metabolism·M Rendell
Nov 1, 1981·Diabetes Care·P G Webb, A M Bonser
May 1, 1981·Annals of Clinical Biochemistry·J P Ashby, B M Frier
Mar 1, 1982·The Journal of Clinical Endocrinology and Metabolism·P M BlixA H Rubenstein

❮ Previous
Next ❯

Citations

Dec 12, 2007·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Christopher R DeWittJavier C Waksman
May 1, 1996·Scandinavian Journal of Gastroenterology·B HeikiusS Lähde
Jan 26, 2016·Metabolic Syndrome and Related Disorders·Harry Robberecht, Nina Hermans
Jul 16, 2010·Cardiovascular Psychiatry and Neurology·Johann SteinerBernhard Bogerts
Dec 8, 2010·Proteomics. Clinical Applications·Paul E OranRandall W Nelson
Feb 1, 1986·Toxicology and Applied Pharmacology·S J KennelS H Safe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2021 Meta ULC. All rights reserved